Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human NF2 Protein, N-His

Catalog #:   YHE08401 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P35240
Protein length: Asp30-Leu239
Overview

Catalog No.

YHE08401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asp30-Leu239

Predicted molecular weight

27.12 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P35240

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Merlin, Neurofibromin-2, Schwannomerlin, NF2, SCH, Moesin-ezrin-radixin-like protein, Schwannomin

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human NF2 protein
References

Atypical Hippo signaling network: uncovering novel insights into head and neck cancer biology and advancements in precision intervention., PMID:40486910

Transcriptional landscape of pleural mesothelioma patients in relation to NF2 gene mutational status., PMID:40484892

Clinical benefits of immune checkpoint inhibitors for malignant peripheral nerve sheath tumors with NF2 mutation: a case report., PMID:40469286

Merlin immunoreactivity fails to predict neurofibromatosis type 2 mutations in human meningiomas., PMID:40447281

BaZiBuShen inhibition of oocyte ferroptosis in primordial follicles through activation of NF2-YAP pathway for the treatment of chemotherapy-induced premature ovarian insufficiency., PMID:40412775

Morphological control of merlin-Rac antagonism in proliferation-promoting signaling., PMID:40392939

Molecular Mechanisms of Tumor Progression and Novel Therapeutic and Diagnostic Strategies in Mesothelioma., PMID:40362535

Radiation-Induced Meningiomas Have an Aggressive Clinical Course: Genetic Signature Is Limited to NF2 Alterations, and Epigenetic Signature Is H3K27me3 Loss., PMID:40359980

Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC., PMID:40346602

Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities., PMID:40343504

Conditioned medium from painful non-NF2 schwannomatosis tumors increases pain behaviors in mice., PMID:40328914

Harnessing the FGFR2/NF2/YAP signaling-dependent necroptosis to develop an FGFR2/IL-8 dual blockade therapeutic strategy., PMID:40319089

[Clinicopathological features of primary thoracic synovial sarcoma: a study of 42 cases]., PMID:40302578

Pathogenic Variants and Allele Loss of the NF2 and LZTR1 Gene in Sporadic Vestibular Schwannoma., PMID:40295009

Similar Allele Frequencies of Two Pathogenic NF2 variants in Each of Nine Sporadic Vestibular Schwannomas., PMID:40280714

Genetics and current research models of Mendelian tumor predisposition syndromes with ocular involvement., PMID:40274012

In-frame insertions of SOX10 are highly enriched and characterize a distinct transcriptomic profile in gastrointestinal schwannomas., PMID:40272443

High de novo mutation rate in Iranian NF2-related schwannomatosis patients with a report of a novel NF2 mutation., PMID:40249415

Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated human Schwann cell proliferation., PMID:40188079

Structure-based optimization of TEAD inhibitors: Exploring a novel subpocket near Glu347 for the treatment of NF2-mutant cancer., PMID:40168885

Utility and limitations of Merlin immunohistochemistry for mesothelioma diagnosis in tissue sections and cell blocks., PMID:40153913

Estrogen receptor α suppresses hepatocellular carcinoma by restricting M2 macrophage infiltration through the YAP-CCL2 axis., PMID:40148834

Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma., PMID:40140675

Strong nuclear expression of HOXB13 is a reliable surrogate marker for DNA methylome profiling to distinguish myxopapillary ependymoma from spinal ependymoma., PMID:40137996

Alterations in the Hippo Signaling Pathway During Adenogenesis Impairment in Postnatal Mouse Uterus., PMID:40106220

Nf2-FAK signaling axis is critical for cranial bone ossification and regeneration., PMID:40075076

Unusual fundus lesion in mosaic neurofibromatosis type 2., PMID:40069121

Effect of Simvastatin on Irradiated Primary Vestibular Schwannoma Cells., PMID:40059781

Gene therapy and genome-editing for schwannoma in NF2-related schwannomatosis: current understanding and future directions., PMID:40055258

NF2-related schwannomatosis: A view from within the inner ear., PMID:40049083

Acylcarnitine Profiling in Meningiomas with Different NF2 Mutation Statuses., PMID:40004036

Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells., PMID:39996452

Anaplastic meningioma in a 6-year-old with somatic YAP1::MAML2 fusion and multiple endocrine neoplasia type 4 (MEN4) syndrome., PMID:39985924

Fundamentals and Applications of Dual-Frequency Magnetic Particle Spectroscopy: Review for Biomedicine and Materials Characterization., PMID:39985275

A genome-wide CRISPR-Cas9 knockout screen using dynamin knockout cells identifies Nf2 and Traf3 as genes involved in dynamin-independent endocytosis., PMID:39978713

Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma., PMID:39969538

Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis., PMID:39937237

NF2 is Essential for Human Endoderm Development., PMID:39921490

Current molecular understanding of central nervous system schwannomas., PMID:39910685

Lead exposure promotes NF2-wildtype meningioma cell proliferation through the Merlin-Hippo signaling pathway., PMID:39894505

NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas., PMID:39886924

Rhabdomyosarcoma With EWSR1::NF2 Gene Fusion: A Case Report Potentially Expanding Its Genetic Spectrum., PMID:39873201

Crb3 and NF2: A dynamic duo that controls assembly of the apical junctions and barrier function via Rho/ROCK signaling., PMID:39868176

Clinical and molecular characteristics and long-term outcomes of pediatric intracranial meningiomas: a comprehensive analysis from a single neurosurgical center., PMID:39856730

Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations., PMID:39846292

WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function., PMID:39841844

Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma., PMID:39788204

[Aggressive mucinous tubular and spindle cell carcinoma of the kidney: a clinicopathological and genetic analysis of four cases]., PMID:39762168

NF2 can mediate the expression of CAMK2A in a tissue specific manner., PMID:39738767

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human NF2 Protein, N-His [YHE08401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only